LymphedemaV1, PubMed, Corpus, bibRecord, 001104

Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.

Identifieur interne : 001104 ( PubMed/Corpus ); précédent : 001103; suivant : 001105

Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.

Auteurs : Pamela L. Ostby ; Jane M. Armer ; Paul S. Dale ; Margaret J. Van Loo ; Cassie L. Wilbanks ; Bob R. Stewart

Source :

Journal of personalized medicine [ 2075-4426 ] ; 2014.

RBID : pubmed:25563360

Abstract

Breast cancer survivors are at increased risk for the development of breast cancer-related lymphedema (BCRL), a chronic, debilitating, and disfiguring condition that is progressive and requires lifelong self-management of symptoms. It has been reported that over 40% of the 2.5 million breast cancer survivors in the United States may meet the criteria for BCRL during their lifetimes. Ongoing surveillance, beginning with pre-operative assessment, has been effective in identifying subclinical lymphedema (LE). A prospective model for surveillance is necessary in order to detect BCRL at an early stage when there is the best chance to reduce risk or slow progression. Physical methods for monitoring and assessment, such as circumferential arm measures, perometry, bioimpedance; exercise programs; prophylactic and early-intervention compression garments; and referral for complete decongestive therapy are all interventions to consider in the development of a BCRL surveillance program. In addition, supportive-educative programs and interactive engagement for symptom self-management should also be implemented. The importance of interdisciplinary collaboration is integral to the success of an effective personalized medicine program in breast cancer-related lymphedema surveillance.

DOI: 10.3390/jpm4030424
PubMed: 25563360

Links to Exploration step

pubmed:25563360

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.</title>
<author><name sortKey="Ostby, Pamela L" sort="Ostby, Pamela L" uniqKey="Ostby P" first="Pamela L" last="Ostby">Pamela L. Ostby</name>
<affiliation><nlm:affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. plo7c9@mail.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
<affiliation><nlm:affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. armer@missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dale, Paul S" sort="Dale, Paul S" uniqKey="Dale P" first="Paul S" last="Dale">Paul S. Dale</name>
<affiliation><nlm:affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. daleps@health.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Loo, Margaret J" sort="Van Loo, Margaret J" uniqKey="Van Loo M" first="Margaret J" last="Van Loo">Margaret J. Van Loo</name>
<affiliation><nlm:affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. vanloomj@health.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wilbanks, Cassie L" sort="Wilbanks, Cassie L" uniqKey="Wilbanks C" first="Cassie L" last="Wilbanks">Cassie L. Wilbanks</name>
<affiliation><nlm:affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. wilbanksc@health.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name>
<affiliation><nlm:affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. stewartb@missouri.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25563360</idno>
<idno type="pmid">25563360</idno>
<idno type="doi">10.3390/jpm4030424</idno>
<idno type="wicri:Area/PubMed/Corpus">001104</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001104</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.</title>
<author><name sortKey="Ostby, Pamela L" sort="Ostby, Pamela L" uniqKey="Ostby P" first="Pamela L" last="Ostby">Pamela L. Ostby</name>
<affiliation><nlm:affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. plo7c9@mail.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
<affiliation><nlm:affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. armer@missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dale, Paul S" sort="Dale, Paul S" uniqKey="Dale P" first="Paul S" last="Dale">Paul S. Dale</name>
<affiliation><nlm:affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. daleps@health.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Loo, Margaret J" sort="Van Loo, Margaret J" uniqKey="Van Loo M" first="Margaret J" last="Van Loo">Margaret J. Van Loo</name>
<affiliation><nlm:affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. vanloomj@health.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wilbanks, Cassie L" sort="Wilbanks, Cassie L" uniqKey="Wilbanks C" first="Cassie L" last="Wilbanks">Cassie L. Wilbanks</name>
<affiliation><nlm:affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. wilbanksc@health.missouri.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name>
<affiliation><nlm:affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. stewartb@missouri.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of personalized medicine</title>
<idno type="ISSN">2075-4426</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Breast cancer survivors are at increased risk for the development of breast cancer-related lymphedema (BCRL), a chronic, debilitating, and disfiguring condition that is progressive and requires lifelong self-management of symptoms. It has been reported that over 40% of the 2.5 million breast cancer survivors in the United States may meet the criteria for BCRL during their lifetimes. Ongoing surveillance, beginning with pre-operative assessment, has been effective in identifying subclinical lymphedema (LE). A prospective model for surveillance is necessary in order to detect BCRL at an early stage when there is the best chance to reduce risk or slow progression. Physical methods for monitoring and assessment, such as circumferential arm measures, perometry, bioimpedance; exercise programs; prophylactic and early-intervention compression garments; and referral for complete decongestive therapy are all interventions to consider in the development of a BCRL surveillance program. In addition, supportive-educative programs and interactive engagement for symptom self-management should also be implemented. The importance of interdisciplinary collaboration is integral to the success of an effective personalized medicine program in breast cancer-related lymphedema surveillance.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">25563360</PMID>
<DateCreated><Year>2015</Year>
<Month>01</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>01</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN>
<JournalIssue CitedMedium="Print"><Volume>4</Volume>
<Issue>3</Issue>
<PubDate><Year>2014</Year>
<Month>Aug</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>Journal of personalized medicine</Title>
<ISOAbbreviation>J Pers Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.</ArticleTitle>
<Pagination><MedlinePgn>424-47</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm4030424</ELocationID>
<Abstract><AbstractText>Breast cancer survivors are at increased risk for the development of breast cancer-related lymphedema (BCRL), a chronic, debilitating, and disfiguring condition that is progressive and requires lifelong self-management of symptoms. It has been reported that over 40% of the 2.5 million breast cancer survivors in the United States may meet the criteria for BCRL during their lifetimes. Ongoing surveillance, beginning with pre-operative assessment, has been effective in identifying subclinical lymphedema (LE). A prospective model for surveillance is necessary in order to detect BCRL at an early stage when there is the best chance to reduce risk or slow progression. Physical methods for monitoring and assessment, such as circumferential arm measures, perometry, bioimpedance; exercise programs; prophylactic and early-intervention compression garments; and referral for complete decongestive therapy are all interventions to consider in the development of a BCRL surveillance program. In addition, supportive-educative programs and interactive engagement for symptom self-management should also be implemented. The importance of interdisciplinary collaboration is integral to the success of an effective personalized medicine program in breast cancer-related lymphedema surveillance.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ostby</LastName>
<ForeName>Pamela L</ForeName>
<Initials>PL</Initials>
<AffiliationInfo><Affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. plo7c9@mail.missouri.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Armer</LastName>
<ForeName>Jane M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. armer@missouri.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dale</LastName>
<ForeName>Paul S</ForeName>
<Initials>PS</Initials>
<AffiliationInfo><Affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. daleps@health.missouri.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Van Loo</LastName>
<ForeName>Margaret J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. vanloomj@health.missouri.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wilbanks</LastName>
<ForeName>Cassie L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo><Affiliation>Ellis Fischel Cancer Center, One Hospital Drive, Columbia, MO 65212, USA. wilbanksc@health.missouri.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stewart</LastName>
<ForeName>Bob R</ForeName>
<Initials>BR</Initials>
<AffiliationInfo><Affiliation>Sinclair School of Nursing, University of Missouri-Columbia, S235 School of Nursing Building, Columbia, MO 65211, USA. stewartb@missouri.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>08</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>J Pers Med</MedlineTA>
<NlmUniqueID>101602269</NlmUniqueID>
<ISSNLinking>2075-4426</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2776-81</RefSource>
<PMID Version="1">9874397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Feb;19(2):642-51</RefSource>
<PMID Version="1">21863361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Oncol Nurs. 2013 Feb;29(1):50-60</RefSource>
<PMID Version="1">23375066</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource>
<PMID Version="1">16379589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2012 Mar;10(1):2-13</RefSource>
<PMID Version="1">22404826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Sep;135(2):591-602</RefSource>
<PMID Version="1">22903688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Can Fam Physician. 2010 Dec;56(12):1277-84</RefSource>
<PMID Version="1">21375063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2011 Jun;19(6):853-7</RefSource>
<PMID Version="1">21240649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2008 Jun 15;112(12):2809-19</RefSource>
<PMID Version="1">18428212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Apr;21(4):1195-201</RefSource>
<PMID Version="1">24558061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nurs Sci Q. 2011 Jan;24(1):57-63</RefSource>
<PMID Version="1">21220577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2001 Mar;110(4):288-95</RefSource>
<PMID Version="1">11239847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2013 Mar;46(1):1-11</RefSource>
<PMID Version="1">23930436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1997 Mar;15(3):974-86</RefSource>
<PMID Version="1">9060536</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Nov 15;116(22):5138-49</RefSource>
<PMID Version="1">20665892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2006 Apr;13(4):491-500</RefSource>
<PMID Version="1">16514477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2009 Nov 15;115(22):5284-95</RefSource>
<PMID Version="1">19685532</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2006 Nov;192(5):636-9</RefSource>
<PMID Version="1">17071198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1984 May;2(5):472-83</RefSource>
<PMID Version="1">6374052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2003 Nov-Dec;52(6):370-9</RefSource>
<PMID Version="1">14639083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2011 May;19(5):631-7</RefSource>
<PMID Version="1">20393753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Nov 20;27(33):5494-6</RefSource>
<PMID Version="1">19826108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Oncol Nurs. 2013 Feb;29(1):41-9</RefSource>
<PMID Version="1">23375065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Hosp Palliat Care. 2014 Feb;31(1):38-44</RefSource>
<PMID Version="1">23423772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2013 Mar;7(1):115-23</RefSource>
<PMID Version="1">23212606</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2005;23(1):76-83</RefSource>
<PMID Version="1">15779870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2010 Jan 12;340:b5396</RefSource>
<PMID Version="1">20068255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PM R. 2012 Aug;4(8):580-601</RefSource>
<PMID Version="1">22920313</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2013 Mar;24(3):517-28</RefSource>
<PMID Version="1">23296457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nurs Health Sci. 2012 Sep;14(3):339-44</RefSource>
<PMID Version="1">22950615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2014 Feb;144(1):71-7</RefSource>
<PMID Version="1">24500108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Phys Ther. 2012 Jan;92(1):152-63</RefSource>
<PMID Version="1">21921254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2010 Jan;37(1):E28-33</RefSource>
<PMID Version="1">20044329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 2009 Dec;38(6):849-59</RefSource>
<PMID Version="1">19819668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2011 Sep;18(9):2500-5</RefSource>
<PMID Version="1">21369739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Oncol Nurs. 2013 Feb;29(1):12-9</RefSource>
<PMID Version="1">23375062</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Self Care Depend Care Nurs. 2009 Oct;17(1):6-15</RefSource>
<PMID Version="1">22872189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2013 May;22(5):1120-6</RefSource>
<PMID Version="1">22689156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2011 Feb 9;305(6):569-75</RefSource>
<PMID Version="1">21304082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Apr;21(4):1237-45</RefSource>
<PMID Version="1">24322530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Oct;117(3):541-7</RefSource>
<PMID Version="1">19082708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Feb;131(3):1029-38</RefSource>
<PMID Version="1">22037785</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Aug 13;361(7):664-73</RefSource>
<PMID Version="1">19675330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Vasc Endovasc Surg. 2013 May;45(5):516-20</RefSource>
<PMID Version="1">23305787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2010 Sep;43(3):118-27</RefSource>
<PMID Version="1">21226414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Nurs. 2012 Jan-Feb;35(1):E18-26</RefSource>
<PMID Version="1">21558848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2001 Aug;68(3):273-82</RefSource>
<PMID Version="1">11727963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Fam Med. 2010 Jul-Aug;42(7):476-8</RefSource>
<PMID Version="1">20628919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2010 Mar;18(3):383-92</RefSource>
<PMID Version="1">19495810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lasers Med Sci. 2014 May;29(3):1289-95</RefSource>
<PMID Version="1">23192573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2013 Jul;22(7):1466-84</RefSource>
<PMID Version="1">23044512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biomed Opt Express. 2010 Jul 15;1(1):114-125</RefSource>
<PMID Version="1">21258451</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2012 Mar;45(1):13-25</RefSource>
<PMID Version="1">22768469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Palliat Med. 2012 Jul;15(7):821-7</RefSource>
<PMID Version="1">22662959</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Breast Cancer Rep. 2013 Jun;5(2):134-144</RefSource>
<PMID Version="1">26246870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2008 Jan;35(1):57-63</RefSource>
<PMID Version="1">18192153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource>
<PMID Version="1">11745212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2011 Jan;38(1):E27-36</RefSource>
<PMID Version="1">21186149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lasers Med Sci. 2006 Jul;21(2):90-4</RefSource>
<PMID Version="1">16673054</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jan 20;27(3):390-7</RefSource>
<PMID Version="1">19064976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2013 Jul;40(4):325-36</RefSource>
<PMID Version="1">23803266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2004 Jun;37(2):73-91</RefSource>
<PMID Version="1">15328760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Oncol Nurs. 2013 Feb;29(1):28-40</RefSource>
<PMID Version="1">23375064</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2008 Jul;35(4):671-80</RefSource>
<PMID Version="1">18591171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>West J Nurs Res. 2011 Dec;33(8):996-1016</RefSource>
<PMID Version="1">20956583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2008 Dec;41(4):186-8</RefSource>
<PMID Version="1">19306665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2012 Jul-Aug;18(4):357-61</RefSource>
<PMID Version="1">22759095</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Dermatol. 2012 Jul;167(1):116-22</RefSource>
<PMID Version="1">22373016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jan;113(2):199-206</RefSource>
<PMID Version="1">18270813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Self Care Depend Care Nurs. 2008;16(1):14-21</RefSource>
<PMID Version="1">22844654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2013 Jul;40(4):383-93</RefSource>
<PMID Version="1">23803270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Fam Nurs. 2014 May;20(2):226-49</RefSource>
<PMID Version="1">24476674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2011 Dec;5(4):320-36</RefSource>
<PMID Version="1">22002586</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4263967</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>04</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>07</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25563360</ArticleId>
<ArticleId IdType="pii">jpm4030424</ArticleId>
<ArticleId IdType="doi">10.3390/jpm4030424</ArticleId>
<ArticleId IdType="pmc">PMC4263967</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001104 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001104 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25563360
   |texte=   Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25563360" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.

Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki